Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem ; 17(22): 7823-30, 2009 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-19819150

RESUMEN

A series of benzazolone compounds were synthesized utilizing benzoxazolinonic and benzothiazolinonic heterocycles as the building unit. The antioxidant activity of these compounds was determined by inhibition of lipid peroxidation. The oxidation of LDL was induced in the presence of CuSO(4) or 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH). The protective action of these compounds against the cytotoxicity was evaluated with lactate dehydrogenase (LDH) activity in bovine aortic endothelial cells (BAECs) and cellular vitality by measuring mitochondrial activity in the presence of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). The best antioxidant activities were observed for phenolic compounds 13 and 14b with ratio R=2.5, 3.2 (5microM). Both of these test substances increased the cell viability significantly as indicated by MTT assay and LDH release assay.


Asunto(s)
Antioxidantes/farmacología , Benzoxazoles/farmacología , Lipoproteínas LDL/metabolismo , Tiazoles/farmacología , Animales , Antioxidantes/síntesis química , Antioxidantes/química , Aorta/citología , Aorta/metabolismo , Aorta/patología , Benzoxazoles/síntesis química , Benzoxazoles/química , Bioensayo , Bovinos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Oxidación-Reducción/efectos de los fármacos , Tiazoles/síntesis química , Tiazoles/metabolismo
2.
Biochem Biophys Res Commun ; 360(3): 627-32, 2007 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-17624315

RESUMEN

Unlike classical protein extraction techniques, proteomic mapping using a selective subcellular extraction kit revealed S100A11 as a new member of the S100 protein family modulated by glucocorticoids in keratinocytes. Glucocorticoids (GC)-induced S100A11 redistribution in the "organelles and membranes" compartment. Microscopic examination indicated that glucocorticoids specifically routed cytoplasmic S100A11 toward perinuclear compartment. Calcium, a key component of skin terminal differentiation, directed S100A11 to the plasma membrane as previously reported. When calcium was added to glucocorticoids, minor change was observed at the proteomic level while confocal microscopy revealed a rapid and dramatic translocation of S100A11 toward plasma membrane. This effect was accompanied by strong nuclear condensation, loss of mitochondrial potential and DNA content, and increased high molecular weight S100A11 immunoreactivity, suggesting corticoids accelerate calcium-induced terminal differentiation. Finally, our results suggest GC-induced S100A11 relocalization could be a key step in both keratinocyte homeostasis and glucocorticoids side effects in human epidermis.


Asunto(s)
Diferenciación Celular , Glucocorticoides/farmacología , Queratinocitos/metabolismo , Proteómica/métodos , Proteínas S100/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Adulto , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Calcio/metabolismo , Calcio/farmacología , Compartimento Celular , Diferenciación Celular/efectos de los fármacos , Membrana Celular/metabolismo , Células Cultivadas , Dexametasona/farmacología , Femenino , Humanos , Queratinocitos/efectos de los fármacos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...